India’s Blood Standards Could Transform Patient Safety as India becomes the first country in the world to introduce exclusive standards for blood and blood components under the Indian Pharmacopoeia 2026.
As the miracle drug cure for cancer Keytruda nears expiry almost seven Indian manufacturers are set on a race to develop generic versions of the drug.
Ebola cases have crossed the 1,000 mark in Central Africa, prompting a fresh warning from the World Health Organization (WHO).
India gets a rare end-to-end ADC manufacturing facility as Shilpa Biologicals, a material subsidiary of Shilpa Medicare, commissioned one of the country’s few fully integrated Antibody-Drug Conjugate (ADC) manufacturing plants.
Translational Research could be the key to unlocking the next phase of growth for India's pharmaceutical sector, according to a new white paper that highlights major gaps in the country's innovation ecosystem.
India has marked a milestone in innovation, Zaynich, a drug that combats multi-drug resistant superbugs.
NPPA has launched an integrated initiative unifying both the Pharma Jan Samadhan portal and the Pharma Sahi Daam portal. The government assures the ease of access and user- friendly experience,thereby promoting the digital governance to the public.
Seasonal flu is emerging as a major public health concern in India, with experts estimating that the infection is linked to nearly 1.2 lakh deaths every year.
Cashless healthcare is set to transform the lives of thousands of workers in the national capital after the Delhi Cabinet approved a new healthcare scheme worth Rs 200 crore annually.
Future FTAs in the Indian pharma industry may look different as India pushes for a stronger pharmaceutical agenda in its trade negotiations.
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")